ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,489,055 | -4.8% | 37,720 | +42.5% | 0.00% | 0.0% |
| Q2 2023 | $4,715,612 | -56.2% | 26,464 | -59.4% | 0.00% | -55.6% |
| Q1 2023 | $10,754,384 | -28.5% | 65,194 | -31.8% | 0.01% | -35.7% |
| Q4 2022 | $15,050,521 | -0.2% | 95,571 | -4.6% | 0.01% | -6.7% |
| Q3 2022 | $15,087,000 | +20.0% | 100,181 | +31.0% | 0.02% | +25.0% |
| Q2 2022 | $12,576,000 | +37.2% | 76,502 | +85.8% | 0.01% | +50.0% |
| Q1 2022 | $9,165,000 | +0.5% | 41,164 | +7.2% | 0.01% | +14.3% |
| Q4 2021 | $9,116,000 | -54.1% | 38,410 | -54.9% | 0.01% | -61.1% |
| Q3 2021 | $19,866,000 | -1.2% | 85,125 | -12.9% | 0.02% | 0.0% |
| Q2 2021 | $20,111,000 | +29.1% | 97,723 | +28.9% | 0.02% | +12.5% |
| Q1 2021 | $15,573,000 | +15.5% | 75,804 | +20.6% | 0.02% | +6.7% |
| Q4 2020 | $13,482,000 | +47.3% | 62,857 | +25.6% | 0.02% | +36.4% |
| Q3 2020 | $9,150,000 | -37.3% | 50,063 | -36.7% | 0.01% | -45.0% |
| Q2 2020 | $14,588,000 | -14.4% | 79,148 | -6.3% | 0.02% | -25.9% |
| Q1 2020 | $17,035,000 | +5.3% | 84,429 | -2.3% | 0.03% | +28.6% |
| Q4 2019 | $16,178,000 | -14.9% | 86,456 | -27.4% | 0.02% | -22.2% |
| Q3 2019 | $19,010,000 | -35.8% | 119,112 | +1.3% | 0.03% | -37.2% |
| Q2 2019 | $29,629,000 | +6.2% | 117,616 | +0.9% | 0.04% | +2.4% |
| Q1 2019 | $27,891,000 | +14.0% | 116,536 | +9.4% | 0.04% | -2.3% |
| Q4 2018 | $24,463,000 | -27.4% | 106,532 | -10.6% | 0.04% | -17.3% |
| Q3 2018 | $33,693,000 | +18.5% | 119,161 | +23.0% | 0.05% | +8.3% |
| Q2 2018 | $28,437,000 | +16.5% | 96,840 | +0.2% | 0.05% | +9.1% |
| Q1 2018 | $24,402,000 | +55.4% | 96,680 | +33.0% | 0.04% | +51.7% |
| Q4 2017 | $15,704,000 | +88.2% | 72,705 | +61.9% | 0.03% | +70.6% |
| Q3 2017 | $8,344,000 | +13.2% | 44,894 | +5.1% | 0.02% | +6.2% |
| Q2 2017 | $7,368,000 | +15.2% | 42,711 | +2.0% | 0.02% | +6.7% |
| Q1 2017 | $6,394,000 | +8.7% | 41,875 | +4.9% | 0.02% | 0.0% |
| Q4 2016 | $5,884,000 | -10.4% | 39,930 | -23.2% | 0.02% | -16.7% |
| Q3 2016 | $6,567,000 | +7.5% | 51,964 | -4.1% | 0.02% | -5.3% |
| Q2 2016 | $6,107,000 | +8.5% | 54,168 | +0.2% | 0.02% | 0.0% |
| Q1 2016 | $5,628,000 | -12.5% | 54,062 | -5.2% | 0.02% | -17.4% |
| Q4 2015 | $6,429,000 | +56.8% | 57,002 | +52.2% | 0.02% | +35.3% |
| Q3 2015 | $4,100,000 | +23.9% | 37,444 | +8.3% | 0.02% | +30.8% |
| Q2 2015 | $3,308,000 | +3.8% | 34,580 | +1.1% | 0.01% | -7.1% |
| Q1 2015 | $3,186,000 | +33.2% | 34,202 | +17.1% | 0.01% | +16.7% |
| Q4 2014 | $2,392,000 | +15.1% | 29,202 | -9.8% | 0.01% | 0.0% |
| Q3 2014 | $2,079,000 | – | 32,390 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |